A Study of Atezolizumab (Tecentriq) to Investigate Long-term Safety and Efficacy in Previously-treated Participants With Locally Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC)

PHASE4CompletedINTERVENTIONAL
Enrollment

619

Participants

Timeline

Start Date

October 25, 2017

Primary Completion Date

April 7, 2022

Study Completion Date

April 7, 2022

Conditions
Carcinoma, Non-Small-Cell Lung
Interventions
DRUG

Atezolizumab

Participants will receive 1200 milligrams (mg) of atezolizumab administered by intravenous infusion on Day 1 of every 3-week cycle until Investigator-assessed loss of clinical benefit, unacceptable toxicity, investigator or participant's decision to withdraw from therapy, or death (whichever occurs first).

Trial Locations (111)

1100

East Avenue Medical Center, Quezon City

1605

The Medical City Hospital; Cancer Research Room, Pasig

1740

University of Perpetual Help System DALTA Medical Center, Las Piñas

2241

Bellevue Medical Center, El-Metn

3010

Hospital General Univ. de Alicante; Servicio de Oncologia, Alicante

4204

University Clinic Golnik, Golnik

4700

Sjællands Universitetshospital, Næstved; Onkologisk Afdeling, Næstved

5000

Odense Universitetshospital, Onkologisk Afdeling R, Odense C

5154

Instituto Regional de Enfermedades Neoplásicas del Sur; Centro de Inv. de Medicina Oncológica, Arequipa

6213

Institut National D'oncologie Sidi Med Benabdellah, Rabat

7100

Vejle Sygehus; Onkologisk Afdeling, Vejle

10103

Clinica CIMCA, San José

10450

Hospital Pulau Pinang; Jabatan Respiratori, George Town

11100

Ospedale Regionale Umberto Parini; S.C. Oncologia, Aosta

11200

Mount Miriam Cancer Hospital, Pulau Pinang

12002

Hospital Provincial de Castellon; Servicio de Oncologia, Castellon

14004

Hospital Universitario Reina Sofia; Servicio de Oncologia, Córdoba

15036

Clinica Internacional, Sede San Borja; Unidad de Investigacion de Clínica Internacional, Lima

15258

Tawam Hospital, Al Ain City

17007

Hospital Universitari de Girona Dr Josep Trueta; Departamento de Oncologia Medica, Girona

18014

Hospital Universitario Virgen de las Nieves; Servicio de Oncologia, Granada

20080

Hospital de Donostia; Servicio de Oncologia Medica, Donostia / San Sebastian

20100

Clinique le Littoral, Casablanca

20162

Asst Grande Ospedale Metropolitano Niguarda; Dipartimento Di Ematologia Ed Oncologia, Milan

23007

Complejo Hospitalario de Jaen-Hospital Universitario Medico Quirurgico; Servicio de Oncologia, Jaén

24125

Cliniche Gavazzeni S.p.A.; Dip. di Oncologia Pneumologica ed Urologica, Bergamo

25123

ASST DEGLI SPEDALI CIVILI DI BRESCIA; Oncologia Medica, Brescia

27003

Hospital Lucus Augusti; Servicio de Oncologia, Lugo

28034

Hospital Ramon y Cajal; Servicio de Oncologia, Madrid

28041

Hospital Universitario 12 de Octubre; Servicio de Oncologia, Madrid

28046

Hospital Universitario La Paz; Servicio de Oncologia, Madrid

28222

Hospital Universitario Puerta de Hierro; Servicio de Oncologia, Majadahonda

28223

Hospital Quiron de Madrid; Servicio de Oncologia, Pozuelo de Alarcón

28702

Hospital Infanta Sofia; Servico de Oncologia, San Sebastián de los Reyes

30000

Centre Hospitalier Universitaire Hassan II, Fes

31008

Complejo Hospitalario de Navarra; Servicio de Oncologia, Pamplona

31100

ULSS2 Marca Trevigiana; UOC Oncologia Medica - Distretto di Treviso, Treviso

33011

Hospital Univ. Central de Asturias; Servicio de Oncologia, Oviedo

35016

Complejo Hospitalario Universitario Insular?Materno Infantil; Servicio de Oncologia, Las Palmas de Gran Canaria

38320

Hospital Universitario de Canarias;servicio de Oncologia, San Cristóbal de La Laguna

39008

Hospital Universitario Marques de Valdecilla; Servicio de Oncologia, Santander

40138

Azienda Ospedaliero-Universitaria S.Orsola-Malpighi; Unità Operativa Oncologia Medica, Bologna

41013

Hospital Universitario Virgen del Rocio; Servicio de Oncologia, Seville

41345

Sahlgrenska Universitetssjukhuset, Lungmedicinkliniken, Gothenburg

42100

Arcispedale Santa Maria Nuova; Medicina Nucleare, Reggio Emilia

46014

Hospital General Universitario de Valencia; Servicio de oncologia, Valencia

46026

Hospital Universitario la Fe; Servicio de Oncologia, Valencia

50009

Hospital Clinico Universitario Lozano Blesa; Servicio de Oncologia, Zaragoza

50134

Azienda Ospedaliero-Universitaria Careggi; SOD Radioterapia, Florence

56124

Azienda Ospedaliera Universitaria Pisana - Ospedale Cisanello; Dipartimento Cardio Toraco Vascolare, Pisa

59100

University Malaya Medical Centre; Clinical Oncology Unit,, Kuala Lumpur

60121

Ospedali Riuniti Di Ancona; Oncology, Ancona

62250

Institute Kanser Negara (IKN), Putrajaya

68000

Oaxaca Site Management Organization, Oaxaca City

78209

Oncologico Potosino, San Luis Potosí City

85028

Ist. Ricovero e Cura a Carattere Scientifico-Centro Rif. Oncologico della Basilica, Rionero in Vulture (PZ)

88100

Campus Universitario S.Venuta; Centro Oncologico T.Campanella, Catanzaro

93586

Hospital Umum Sarawak; Oncology and Radiotherapy, Kuching

95126

Ospedale Cannizzaro, Oncologia, Catania

97125

Investigacion Clinica Merida, Mérida

100006

Beijing Hospital, Beijing

100853

Chinese PLA General Hospital, Beijing

111321

Organizacion Sanitas Internacional, Bogota, D.C.

215006

First Affiliated Hospital of Soochow University, Suzhou

250117

Shandong Cancer Hospital, Jinan

450008

Henan Cancer Hospital, Zhengzhou

C1118AAT

Hospital Aleman, Caba

F5300COE

Centro Oncologico Riojano Integral (CORI), La Rioja

38082-049

CETUS Hospital Dia Oncologia, Uberaba

90035-903

Hospital das Clinicas - UFRGS, Porto Alegre

01327-001

Hospital Alemao Oswaldo Cruz, São Paulo

115 22

Anticancer Hospital Ag Savas; 1St Dept of Internal Medicine, Athens

115 27

Uoa Sotiria Hospital; Oncology, Athens

145 64

Agioi Anargyroi; 3Rd Dept. of Medical Oncology, Athens

711 10

Univ General Hosp Heraklion; Medical Oncology, Heraklion

265 04

University Hospital of Patras Medical Oncology, Pátrai

570 01

Diavalkaniko Hospital, Thessaloniki

01010

Oncomedica, Guatemala City

00161

Policlinico Umberto i di Roma; dip. Scienze Radiologiche, Oncologiche, Anatomopatologiche, Rome

00184

AZ. Ospedaliera San Giovanni - Addolorata, Rome

09121

Ospedale Oncologico A.Businco; Div. Oncologia Medica II, Cagliari

LV-1002

Pauls Stradins Clinical University Hospital, R?ga

LV-1079

Riga East Clinical University Hospital Latvian Oncology Centre, Riga

2063 1111

Hotel Dieu de France; Oncology, Beirut

03100

Health Pharma Professional Research, Mexico City

04700

Centro Oncologico Internacional, Mexico City

3813 TZ

Meander Medisch Centrum, Amersfoort

6815 AD

Ziekenhuis Rijnstate, Arnhem

4818 CK

Amphia Ziekenhuis; Afdeling Longziekten, Breda

1213 HX

Tergooiziekenhuizen, loc. Hilversum, Hilversum

6500 HB

UMC Radboud Nijmegen, Nijmegen

8025 AB

Isala, Zwolle

0832

The Panama Clinic, Panama City

44-101

Narodowy Instytut Onkologii Oddzial Gliwice; II Klinika Radioterapii i Chemioterapii, Gliwice

10-357

Samodzielny Publiczny Zespol Gruzlicy i Chorob Pluc w Olsztynie, Olsztyn

05-400

Mazowieckie Centrum Leczenia Chorob Pluc I Gruzlicy; Oddzial Iii, Otwock

60-569

Szpital Kliniczny; Przemienienia Panskiego;Uniwersytetu Medyczny im.; Karola Marcinkowskiego w Pozna, Poznan

02-781

Narod.Inst.Onkol. im. M.Sklodowskiej - Curie-Panst.Inst.Bad; Klinika Nowot.Pluca i Klatki Piers, Warsaw

07014

Hospital Universitario Son Espases; Servicio de Oncologia, Palma de Mallorca

08003

Hospital del Mar; Servicio de Oncologia, Barcelona

08036

Hospital Clínic i Provincial; Servicio de Hematología y Oncología, Barcelona

08041

Hospital de la Santa Creu i Sant Pau; Servicio de Oncologia, Barcelona

171 76

Karolinska Universitetssjukhuset, Solna; Kliniska prövningsenheten Z:4:01, Stockholm

751 85

Uppsala University Hospital; Department of Oncology, Uppsala

BA1 3NG

Royal United Hospital, Bath

B9 5SS

Birmingham Heartlands Hospital ; Department of Respiratory Medicine (Rm 30), Birmingham

HU16 5JQ

Castle Hill Hospital; The Queen's Centre for Oncology & Haematology, Hull

FK5 4QE

Forth Valley Royal Hospital ; Oncology Department, Larbert

SW10 9TH

Chelsea & Westminster Hospital, London

HA6 2RN

Mount Vernon Cancer Centre, Northwood

WV10 0QP

New Cross Hospital, Wolverhampton

All Listed Sponsors
lead

Hoffmann-La Roche

INDUSTRY

NCT03285763 - A Study of Atezolizumab (Tecentriq) to Investigate Long-term Safety and Efficacy in Previously-treated Participants With Locally Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC) | Biotech Hunter | Biotech Hunter